Use of a novel abdominal aortic tourniquet to reduce or eliminate flow in the common femoral artery in human subjects

Matt Lyon, Stephen A. Shiver, Eric Mark Greenfield, Bradford Zahner Reynolds, E. Brooke Lerner, Ian S. Wedmore, Richard B. Schwartz

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Background: Penetrating injuries of proximal femoral and iliac vessels are a common cause of death on the battlefield. Previous studies have shown that by applying 80 lb to 140 lb of pressure externally over the distal abdominal aorta, flow can be ceased in the common femoral artery (CFA). It has also been demonstrated that in a porcine model, an externally applied pneumatic abdominal aortic tourniquet (AAT) can occlude the aorta and inferior vena cava for 60 minutes without bowel injury or significant potassium elevations.The objectives of this study were (1) determine if AAT use in humans results in flow cessation in the CFA, (2) measure the pressure required to cease flow in the CFA, and (3) measure discomfort associated with application of the AAT. Methods: Pulse wave Doppler measurements were taken in supine volunteers at the right CFA. The AAT was placed just above the iliac crests over the anterior abdomen. The AAT was inflated using a hand pump with an integrated manometer. Measurements were taken every 30 mm Hg. Discomfort was measured using a 10-point pain scale. Results: In all subjects, flow was reduced in the CFA. Flow ceased in seven of nine subjects at a median pressure of 180 mm Hg (150-230 mm Hg). Median discomfort at ceasing of flow was 7 (3-10), returning to 0 after device removal. Conclusion: The AAT device was effective at reducing flow in the CFA and ceased flow in most of the subjects. Application of the device was associated with discomfort varying from moderate to severe and resolving with device removal.

Original languageEnglish (US)
Pages (from-to)S103-S105
JournalJournal of Trauma and Acute Care Surgery
Volume73
Issue number2 SUPPL. 1
DOIs
StatePublished - Aug 1 2012

Fingerprint

Tourniquets
Femoral Artery
Device Removal
Pressure
Equipment and Supplies
Abdominal Aorta
Wounds and Injuries
Inferior Vena Cava
Thigh
Abdomen
Aorta
Cause of Death
Volunteers
Potassium
Swine
Hand
Pain

Keywords

  • Hemorrhage
  • abdominal tourniquet
  • combat casualty care
  • junctional hemorrhage

ASJC Scopus subject areas

  • Surgery
  • Critical Care and Intensive Care Medicine

Cite this

Use of a novel abdominal aortic tourniquet to reduce or eliminate flow in the common femoral artery in human subjects. / Lyon, Matt; Shiver, Stephen A.; Greenfield, Eric Mark; Reynolds, Bradford Zahner; Lerner, E. Brooke; Wedmore, Ian S.; Schwartz, Richard B.

In: Journal of Trauma and Acute Care Surgery, Vol. 73, No. 2 SUPPL. 1, 01.08.2012, p. S103-S105.

Research output: Contribution to journalArticle

@article{8c31ea4c92d14f25a486f1287e27d6a9,
title = "Use of a novel abdominal aortic tourniquet to reduce or eliminate flow in the common femoral artery in human subjects",
abstract = "Background: Penetrating injuries of proximal femoral and iliac vessels are a common cause of death on the battlefield. Previous studies have shown that by applying 80 lb to 140 lb of pressure externally over the distal abdominal aorta, flow can be ceased in the common femoral artery (CFA). It has also been demonstrated that in a porcine model, an externally applied pneumatic abdominal aortic tourniquet (AAT) can occlude the aorta and inferior vena cava for 60 minutes without bowel injury or significant potassium elevations.The objectives of this study were (1) determine if AAT use in humans results in flow cessation in the CFA, (2) measure the pressure required to cease flow in the CFA, and (3) measure discomfort associated with application of the AAT. Methods: Pulse wave Doppler measurements were taken in supine volunteers at the right CFA. The AAT was placed just above the iliac crests over the anterior abdomen. The AAT was inflated using a hand pump with an integrated manometer. Measurements were taken every 30 mm Hg. Discomfort was measured using a 10-point pain scale. Results: In all subjects, flow was reduced in the CFA. Flow ceased in seven of nine subjects at a median pressure of 180 mm Hg (150-230 mm Hg). Median discomfort at ceasing of flow was 7 (3-10), returning to 0 after device removal. Conclusion: The AAT device was effective at reducing flow in the CFA and ceased flow in most of the subjects. Application of the device was associated with discomfort varying from moderate to severe and resolving with device removal.",
keywords = "Hemorrhage, abdominal tourniquet, combat casualty care, junctional hemorrhage",
author = "Matt Lyon and Shiver, {Stephen A.} and Greenfield, {Eric Mark} and Reynolds, {Bradford Zahner} and Lerner, {E. Brooke} and Wedmore, {Ian S.} and Schwartz, {Richard B.}",
year = "2012",
month = "8",
day = "1",
doi = "10.1097/TA.0b013e3182606219",
language = "English (US)",
volume = "73",
pages = "S103--S105",
journal = "Journal of Trauma and Acute Care Surgery",
issn = "2163-0755",
publisher = "Lippincott Williams and Wilkins",
number = "2 SUPPL. 1",

}

TY - JOUR

T1 - Use of a novel abdominal aortic tourniquet to reduce or eliminate flow in the common femoral artery in human subjects

AU - Lyon, Matt

AU - Shiver, Stephen A.

AU - Greenfield, Eric Mark

AU - Reynolds, Bradford Zahner

AU - Lerner, E. Brooke

AU - Wedmore, Ian S.

AU - Schwartz, Richard B.

PY - 2012/8/1

Y1 - 2012/8/1

N2 - Background: Penetrating injuries of proximal femoral and iliac vessels are a common cause of death on the battlefield. Previous studies have shown that by applying 80 lb to 140 lb of pressure externally over the distal abdominal aorta, flow can be ceased in the common femoral artery (CFA). It has also been demonstrated that in a porcine model, an externally applied pneumatic abdominal aortic tourniquet (AAT) can occlude the aorta and inferior vena cava for 60 minutes without bowel injury or significant potassium elevations.The objectives of this study were (1) determine if AAT use in humans results in flow cessation in the CFA, (2) measure the pressure required to cease flow in the CFA, and (3) measure discomfort associated with application of the AAT. Methods: Pulse wave Doppler measurements were taken in supine volunteers at the right CFA. The AAT was placed just above the iliac crests over the anterior abdomen. The AAT was inflated using a hand pump with an integrated manometer. Measurements were taken every 30 mm Hg. Discomfort was measured using a 10-point pain scale. Results: In all subjects, flow was reduced in the CFA. Flow ceased in seven of nine subjects at a median pressure of 180 mm Hg (150-230 mm Hg). Median discomfort at ceasing of flow was 7 (3-10), returning to 0 after device removal. Conclusion: The AAT device was effective at reducing flow in the CFA and ceased flow in most of the subjects. Application of the device was associated with discomfort varying from moderate to severe and resolving with device removal.

AB - Background: Penetrating injuries of proximal femoral and iliac vessels are a common cause of death on the battlefield. Previous studies have shown that by applying 80 lb to 140 lb of pressure externally over the distal abdominal aorta, flow can be ceased in the common femoral artery (CFA). It has also been demonstrated that in a porcine model, an externally applied pneumatic abdominal aortic tourniquet (AAT) can occlude the aorta and inferior vena cava for 60 minutes without bowel injury or significant potassium elevations.The objectives of this study were (1) determine if AAT use in humans results in flow cessation in the CFA, (2) measure the pressure required to cease flow in the CFA, and (3) measure discomfort associated with application of the AAT. Methods: Pulse wave Doppler measurements were taken in supine volunteers at the right CFA. The AAT was placed just above the iliac crests over the anterior abdomen. The AAT was inflated using a hand pump with an integrated manometer. Measurements were taken every 30 mm Hg. Discomfort was measured using a 10-point pain scale. Results: In all subjects, flow was reduced in the CFA. Flow ceased in seven of nine subjects at a median pressure of 180 mm Hg (150-230 mm Hg). Median discomfort at ceasing of flow was 7 (3-10), returning to 0 after device removal. Conclusion: The AAT device was effective at reducing flow in the CFA and ceased flow in most of the subjects. Application of the device was associated with discomfort varying from moderate to severe and resolving with device removal.

KW - Hemorrhage

KW - abdominal tourniquet

KW - combat casualty care

KW - junctional hemorrhage

UR - http://www.scopus.com/inward/record.url?scp=84864622258&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864622258&partnerID=8YFLogxK

U2 - 10.1097/TA.0b013e3182606219

DO - 10.1097/TA.0b013e3182606219

M3 - Article

C2 - 22847077

AN - SCOPUS:84864622258

VL - 73

SP - S103-S105

JO - Journal of Trauma and Acute Care Surgery

JF - Journal of Trauma and Acute Care Surgery

SN - 2163-0755

IS - 2 SUPPL. 1

ER -